Novartis Drug Pricing Agreement

By João L. Carapinha

January 7, 2026

Novartis reached a drug pricing agreement with the US government that lowers prices for innovative medicines, while the firm will launch future drugs at comparable prices across high-income countries. Novartis also introduces direct-to-patient pla...
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Weight Loss: Advances in Hormone-Based Obesity Treatments
Advancing Kidney Transplant Transparency Through Patient Involvement
AI in South African Healthcare: Professionals’ Confidence in Reducing A...
Health Misinformation Autism: The Dangers of Politicized Science in Vaccine a...
The Market Dynamics of Track One Patent Strategy in Pharmaceuticals
Ending Unproven Fertility Treatments: NICE Calls for Evidence-Based Care in C...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...
AI in Real-World Evidence: Insights from Mitch Higashi
DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expan...